Evidence map›Paper›PMID 40330183›Full record

ArticleIranian journal of public health2025

Predisposing Factors for Idiopathic Granulomatous Mastitis: A Large Prospective Multicentric Study.

Sadaf Alipour, Maryam Tabatabaeian, Parisa Aziminezhadan, Azin Saberi, Maryam Daneshpazhooh, Ramesh Omranipour, Paniz Famil-Amir, Najmeh Ahmadi, Maryam Sarkardeh, Nahid Nafissi and 9 more

Abstract read
In one paragraph

Article in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sadaf AlipourBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam TabatabaeianAnahid Clinic, Isfahan, Iran.
Parisa AziminezhadanAziminezhadan Breast Clinic, Tehran, Iran.
Azin SaberiDepartment of Surgery, Arash Women's Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Maryam DaneshpazhoohAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ramesh OmranipourBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Paniz Famil-AmirAziminezhadan Breast Clinic, Tehran, Iran.
Najmeh AhmadiAnahid Clinic, Isfahan, Iran.
Maryam SarkardehDepartment of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nahid NafissiClinical Research Development Center (RCRDC), Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Azita MazinaniClinical Research Development Center (RCRDC), Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Azadeh JoulaeeDepartment of Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahla AstarakiAnahid Clinic, Isfahan, Iran.
Zohreh Zahernia-ShahrbabakiAnahid Clinic, Isfahan, Iran.
Reihane Tahery-MehrBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam Gharini-AhmadiDepartment of Nursing, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Behnaz Khajeh-Ali-BeikiDepartment of Nursing, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Marzieh OroujiDepartment of Nursing, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Bita EslamiBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Idiopathic granulomatous mastitis (IGM) is a chronic breast disease with unknown pathophysiological and clinical aspects. Therefore, we designed this multi-center prospective case-control study to explore and clarify the risk factors with an acceptable sample size. Methods: From March 2021 to December 2023, five hundred-four women with a histologically proven IGM were entered into the IGM group and 504 women with healthy breasts were included in the control group across nine centers. Participants' information was obtained by trained staff. Multivariate binary logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CI) for the associations between variables and IGM. Results: The mean age of all participants was 34.92 ± 7.12 yr. The previous history of diseases as a whole, was significantly higher in the IGM group (33.1%) compared with the control group (26.6%). Logistic regression showed that previous lactation (OR= 7.51, 95% CI= 2.37-23.77) and a positive history of diabetes (OR = 4.23, 95% CI= 1.32-13.51) had a positive association with IGM, while OCP use (OR = 0.70, 95% CI= 0.52-0.93) was associated with IGM reversely. Conclusion: The history of breastfeeding and not its duration is associated with a 7-fold increase in the rate of IGM. Furthermore, previous history of diabetes is a risk factor, while OCP use is a protective factor against IGM. We are designing another study to further investigate the relationship between breastfeeding, milk stasis, and IGM, based on our findings.

Indexed as

BreastfeedingCase-control studyGranulomatous mastitisRisk factor

Identifiers

PMID40330183
PMCPMC12051815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.